Evidence map›Paper›PMID 41699449›Full record

SynthesisJournal of psychopharmacology (Oxford, England)2026

Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature.

Marten Kase, Karl Kristjan Kaup, Jaan Aru

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of psychopharmacology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marten KaseInstitute of Psychology, University of Tartu, Estonia.ORCID 0009-0005-4560-104X
Karl Kristjan KaupInstitute of Computer Science, University of Tartu, Estonia.ORCID 0009-0003-6126-6822
Jaan AruInstitute of Computer Science, University of Tartu, Estonia.ORCID 0000-0003-3927-452X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We carried out a systematic review of modern-era (1990-2025) placebo-controlled studies assessing the acute and post-acute effects of lysergic acid diethylamide, dimethyltryptamine and psilocybin on cognitive and psychological functions. From February 28 to March 19, 2025, PubMed and APA PsychINFO were systematically searched for placebo-controlled studies examining the influence of psychedelics on empathy, reaction time, attention, inhibition, emotional processing, memory, cognitive flexibility, and related cognitive functions using experimental methods. Additional searches were done in Google Scholar. The systematic review included 32 studies. Psychedelics tended to enhance emotional empathy but had no effect on cognitive empathy. Psychedelics impaired, enhanced or had no effect on memory depending on the task and timing of the assessment. Dose-dependent impairments were seen in many of the reaction time, attention, and inhibition tasks, although some studies found no effects. Some studies found impaired recognition of negative stimuli under the acute effects of psychedelics. The findings regarding cognitive flexibility were mixed. Many studies had small samples, and it is hard to find a reliable placebo due to psychedelics' unique subjective effects. Future studies should use bigger samples and also study more longitudinal effects of psychedelics on cognitive and psychological functions.

Indexed as

CognitionHallucinogensLysergic Acid DiethylamideN,N-DimethyltryptaminePsilocybinAttentionCognitive EnhancementCognitive FlexibilityEmotionsEmpathyHumansMemoryReaction TimeHallucinogensLysergic Acid DiethylamideN,N-DimethyltryptaminePsilocybincognitive functionsDMTLSDpsilocybinpsychological functions

Identifiers

PMID41699449
PMCPMC13415910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.